Upcoming Catalysts On The Radar: ARQL & GBT
- Amp Team
- Oct 30, 2018
- 1 min read
ASH abstracts coming 12/1. Looking forward to $ARQL update on reversible Btk inhib ARQ 531 for C481S mutants (Ibrutinib resistance) in B cell cancers and $GBT Hope Kids higher dose cohort for Voxelotor/sickle cell.